Takeda Pharmaceutical Co., Ltd. (TAK)
15.96
-0.19
(-1.18%)
USD |
NYSE |
May 29, 16:00
15.97
+0.01
(+0.06%)
Pre-Market: 20:00
Takeda Pharmaceutical Market Cap : 50.41B for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 286.54B |
| Johnson & Johnson | 542.42B |
| Eli Lilly & Co. | 985.37B |
| Sanofi | 106.51B |
| AstraZeneca PLC | 287.94B |
Market Cap Related Metrics
| PE Ratio | 39.35 |
| PS Ratio | 1.694 |
| PEG Ratio | 0.4536 |
| Price to Book Value | 1.032 |
| Price | 15.96 |
| Earnings Yield | 2.54% |
| PEGY Ratio | 0.433 |
| Operating PE Ratio | 14.01 |